Abstract
An ideal combination: The vaccine A is obtained by conjugation of the synthetic tumor-associated sialyl-TN-MUC1 glycopeptide antigen to tetanus toxoid (molecular weight >150 000). Vaccine A induces a very strong and selective immune response against the glycopeptide structure in wild-type mice (Balb/c).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
